SEI Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

SEI Investments’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.57M	Sell	63,571 -13,501	-18%	-$322K	﹤0.01%	2126
2025 Q4	$1.8M	Buy	77,072 +430	+0.6%	+$9.58K	﹤0.01%	1909
2025 Q3	$1.51M	Buy	76,642 +9,344	+14%	+$192K	﹤0.01%	1800
2025 Q2	$1.46M	Sell	67,298 -34,975	-34%	-$826K	﹤0.01%	1768
2025 Q1	$2.48M	Sell	102,273 -14,045	-12%	-$316K	﹤0.01%	1554
2024 Q4	$2.43M	Buy	116,318 +14,849	+15%	+$319K	﹤0.01%	1614
2024 Q3	$2.02M	Buy	101,469 +17,011	+20%	+$315K	﹤0.01%	1674
2024 Q2	$1.31M	Buy	84,458 +1,098	+1%	+$17.1K	﹤0.01%	1815
2024 Q1	$1.33M	Buy	83,360 +32,621	+64%	+$492K	﹤0.01%	1779
2023 Q4	$853K	Buy	50,739 +8,483	+20%	+$116K	﹤0.01%	1928
2023 Q3	$494K	Sell	42,256 -3,241	-7%	-$43.4K	﹤0.01%	2111
2023 Q2	$611K	Sell	45,497 -29,640	-39%	-$427K	﹤0.01%	2059
2023 Q1	$1.25M	Buy	75,137 +29,150	+63%	+$481K	﹤0.01%	1802
2022 Q4	$855K	Sell	45,987 -173,465	-79%	-$2.67M	﹤0.01%	1819
2022 Q3	$2.82M	Sell	219,452 -129,714	-37%	-$1.54M	0.01%	1377
2022 Q2	$2.44M	Buy	349,166 +53,452	+18%	+$392K	0.01%	1456
2022 Q1	$2.44M	Buy	295,714 +121,870	+70%	+$862K	﹤0.01%	1467
2021 Q4	$1.18M	Hold	173,844	–	–	﹤0.01%	1782
2021 Q3	$921K	Buy	+173,844	New	+$951K	﹤0.01%	1808
2021 Q2	–	Sell	-18,905	Closed	-$63K	–	2557
2021 Q1	$63K	Hold	18,905	–	–	﹤0.01%	2455
2020 Q4	$63K	Hold	18,905	–	–	﹤0.01%	2431
2020 Q3	$56K	Sell	18,905 -58,179	-75%	-$228K	﹤0.01%	2369
2020 Q2	$356K	Hold	77,084	–	–	﹤0.01%	2006
2020 Q1	$297K	Buy	77,084 +64,316	+504%	+$264K	﹤0.01%	1942
2019 Q4	$48K	Buy	+12,768	New	+$59.7K	﹤0.01%	2363
2019 Q2	–	Sell	-112,169	Closed	-$572K	–	2460
2019 Q1	$572K	Buy	+112,169	New	+$330K	﹤0.01%	1822
2018 Q2	–	Sell	-1,250	Closed	-$3K	–	3635
2018 Q1	$3K	Hold	1,250	–	–	﹤0.01%	3152
2017 Q4	$5K	Buy	+1,250	New	+$4.13K	﹤0.01%	2940

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SEI Investments's CPRX Position: Q1 2026 in Review

SEI Investments reduced its Catalyst Pharmaceutical (CPRX) stake by 18% in Q1 2026, selling an estimated $322K and leaving 63,571 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #2126.

SEI Investments first reported a position in CPRX in Q4 2017 and has held it in 28 quarters since. The position peaked at $2.82M in Q3 2022. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

SEI Investments held 63,571 shares of Catalyst Pharmaceutical worth $1.57M as of Q1 2026.
SEI Investments sold 13,501 Catalyst Pharmaceutical shares in Q1 2026, an estimated $322K.
Catalyst Pharmaceutical made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2126 holding.
SEI Investments first reported a position in Catalyst Pharmaceutical in Q4 2017 and has held it in 28 quarters since.
SEI Investments's Catalyst Pharmaceutical position peaked at $2.82M in Q3 2022.
380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.